ADVERTISEMENT
Laurus Labs, Supriya Lifesciences, Divi’s Labs— DRChoksey's Top Stock Picks In Pharma Pack; Q1 Results Preview
Pharma Q1 Results Preview: Lupin is expected to return to double-digit growth with new launches scale up, adds DRChoksey
09 Jul 2025, 01:28 PM IST i

Save

As per Pharma rack data, during April 2025, the Indian pharmaceutical market grew by 7.8% YoY, led by improved price realization, modest new launches, and muted volume growth.
(Photo Source: Lance Reis on Unsplash)
Although the threat of US tariffs on Indian pharmaceutical imports has created uncertainty and market volatility, so far, the sector has been largely exempted, as it plays a critical role in the US healthcare. However, the risk lingers on companies specifically with higher US exposure. India and the US are engaged in negotiations, and the long-term outlook will depend on the evolution of trade policies and the ability of Indian pharm...

I’m already a Subscriber
To continue reading this story
Subscribe to Unlock & Enjoy your
Subscriber-Only benefits
Subscriber-Only benefits
Choose a plan
Renews automatically. Cancel anytime.
Access to
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Subscriber-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Subscriber-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
ADVERTISEMENT